Caricamento...
Germline variants predictive of tumor mutational burden and immune checkpoint inhibitor efficacy
High tumor mutational burden (TMB) is associated with response to checkpoint blockade in several cancers. We identify pathogenic germline variants associated with increased TMB (GVITMB). GVITMB were found in 7 genes using a pan-cancer approach (APC, FANCL, SLC25A13, ERCC3, MSH6, PMS2, and TP53) and...
Salvato in:
| Pubblicato in: | iScience |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7988326/ https://ncbi.nlm.nih.gov/pubmed/33786423 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.isci.2021.102248 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|